Charan focuses his practice on patent litigation and other intellectual property matters, primarily for pharmaceutical and technology clients. His trial focus helps him work with clients to craft efficient litigation strategies that meet their business objectives.
Charan advises clients in patent and other intellectual property litigation, primarily involving pharmaceutical, software, communications network, medical device, mechanical and biotechnology inventions. He represents clients through all stages of litigation, including trial, inter partes review and other PTAB proceedings, and appeals. Charan also leverages his trial experience to advise clients on IP portfolio development, provide pre-litigation and freedom-to-operate opinions, prosecute high-value patents relating to a variety of technologies, and review key assets in transactional due diligence.
He represents clients in various types of litigation, adapting the core strategy to fit clients’ business needs and objectives. His outside-the-box approach is highly valued in branded-side Hatch- Waxman Abbreviated New Drug Application (ANDA) patent litigation and bet-the-company patent litigation between multinational competitors. His ability to winnow cases to key strategic issues and evidence gives technology clients an advantage in efficiently defending against non-practicing entity litigation. Charan’s broad technical background makes him well-suited both to delve into obscure points with experts while still simplifying complex issues for a lay audience. For this reason, Charan has been retained by clients to handle IP disputes relating to diverse technologies ranging from software, Internet routing and content delivery technologies, PET scanner crystallography, infrared missile seekers, genetically modified crops, automation equipment, mobile telephone handsets and computer hardware, and communications protocols.
Representative Experience
- Second-chaired trial for a global medical imaging company in litigation against a key competitor asserting patents related to scintillation crystals used in PET scanners, helping to secure a $50M+ jury verdict and award for the client.*
- Second-chaired arbitration for a global industrial automation company defending against allegations of trade secret misappropriation and breach of contract relating to remote monitoring and control technology, resulting in an award of over $1M in attorney’s fees to the client.*
- Obtained summary judgment of non-infringement and unenforceability due to inequitable conduct on behalf of a generic pharmaceutical client in Hatch-Waxman ANDA litigation.*
- Represented a global agricultural chemical company in patent ownership litigation involving three other parties claiming rights to genetically modified crop technology, resulting in a favorable settlement for the client on the eve of trial.*
- Led the defense of a leading maker of consumer electronic devices in multiple patent litigations against non-practicing entities that were favorably resolved without any payment from the client.*
- Argued an appeal before the Federal Circuit on behalf of appellee seeking reversal of summary judgment of non-infringement based on prosecution history estoppel in a Hatch-Waxman ANDA litigation.*
- Represented a global innovator pharmaceutical company as trial counsel in Hatch-Waxman ANDA litigation relating to a leading opioid dependence treatment product, examining key expert witnesses relating to the validity of Orange Book-listed patents.*
-
Defended a designer and manufacturer of surfing simulator water rides in bet-the-company patent and breach of contract litigations and related inter partes review proceedings and Federal Circuit appeals. These representations resulted in one patent being canceled, another being found invalid and a district court award of significant attorneys’ fees.*
- Defended a content delivery network client in multi-patent litigation that resulted in a full defense jury verdict.*